Pharmaceutical giant Pfizer announced Wednesday that it has struck a deal to purchase development and commercialization rights to some of London-based peer AstraZeneca’s antibiotics businesses
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
























